Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority)

BJU International

Volumn 109, Issue 5, 2012, Pages 722-730

  Biester, Katharina ^a   Skipka, Guido ^a   Jahn, Rebecca ^b   Buchberger, Barbara ^b   Rohde, Volker ^c   Lange, Stefan ^a  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c HELIOS AGNES KARLL HOSPITAL   (Germany)

Author keywords

benign prostatic hyperplasia; non inferiority; non standard surgical treatments; systematic review; therapeutic equivalence; transurethral resection of the prostate

Indexed keywords

ADULT; AGED; ASYMPTOMATIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HOLMIUM LASER; HUMAN; LASER; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THULIUM LASER; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; MALE; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 84860421208     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10512.x     Document Type: Review

References (35)

1. Verhamme K, Dieleman J, Bleumink G, van der Lei J, Sturkeboom M,. Incidence and prevalence of lower urinary tract symptoms: suggestive of benigne prostatic hyperplasia in primary care-the triumph project. Eur Urol 2002; 42: 323-8 (Pubitemid 35175791)
2. Berges RR, Pientka L, Hofner K, Senge T, Jonas U,. Male lower urinary tract symptoms and related health care seeking in Germany. European Urology 2001; 39: 682-7 (Pubitemid 32679638)
3. American Urological Association Education and Research I. BPH: Guideline on the Management of Benign Prostatic Hyperplasia. Baltimore: American Urological Association Education and Research, Inc., 2003. [updated 2006]; Available at:. Accessed September 2010
4. Food and Drug Administration. Non-Inferiority Clinical Trials: Draft Guidance. Rockville: Food and Drug Administration, 2010. [updated March 2010]; Available at:. Accessed January 2011
5. European Medicines Agency. Guideline on the choice of the non-inferiority margin. 2005. Available at:. Accessed October 2009
6. Institute for Quality and Efficiency in Health Care. Non-drug local procedures in the treatment of benign prostatic hyperplasia [Nichtmedikamentöse lokale Verfahren zur Behandlung der benignen Prostatahyperplasie]: final Report; Commission N04-01. 2008. Available at:. Accessed October 2009
7. Institute for Quality and Efficiency in Health Care. Non-drug local procedures for treatment of benign prostatic syndrome [Nichtmedikamentöse lokale Verfahren zur Behandlung der benignen Prostatasyndroms]- Update-: rapid Report; Commsion N09-01. 2009. Available at:. Accessed February 2010
8. Institute for Quality and Efficiency in Health Care. General methods: version 3.0. 2008/5/27. Available at:. Accessed October 2009
9. Deeks J, Altman DG, Bradburn MJ,. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In, Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care, London: BMJ Publishing Group, 2001: 285-312
10. Carraro JC, Raynaud JP, Koch G, et al,. Comparison of phytotherapy (Permixon) with Finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. The Prostate 1996; 29: 231-40 (Pubitemid 26365288)
11. Barry MJ, Williford WO, Chang Y, et al,. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 1995; 154: 1770-4
12. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS,. Interpreting treatment effects in randomised trials. BMJ 1998; 316: 690-3 (Pubitemid 28121037)
13. Lange S, Freitag G,. Choice of delta: requirements and reality; results of a systematic review. Biom J 2005; 47: 12-27 (Pubitemid 40390435)
14. Ahyai SA, Lehrich K, Kuntz RM,. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 2007; 52: 1456-63
15. Kuntz RM, Ahyai S, Lehrich K, Fayad A,. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172: 1012-6 (Pubitemid 39096451)
16. Mavuduru RM, Mandal AK, Singh SK, et al,. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urologia Internationalis 2009; 82: 130-5
17. Fu WJ, Zhang X, Yang Y, et al,. Comparison of 2-mum continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 2010; 75: 194-9
18. Gilling P, Cass C, Cresswell M, Fraundorfer M,. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996; 47: 48-51 (Pubitemid 26038303)
19. European Medicines Agency. Note for guidance on choice of control group in clinical trials (CPMP/ICH/364/96): ICH topic E 10; step 5. 2001. Available at:. Accessed October 2009
20. International Conference on Harmonisation. ICH harmonised tripartite guideline: statistical principles for clinical trials. Stat Med 1999; 18: 1905-42
21. Barkun JS, Aronson JK, Feldman LS, et al,. Evaluation and stages of surgical innovations. Lancet 2009; 374: 1089-96
22. Ergina PL, Cook JA, Blazeby JM, et al,. Challenges in evaluating surgical innovation. Lancet 2009; 374: 1097-104
23. McCulloch P, Altman DG, Campbell WB, et al,. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009; 374: 1105-12
24. Lourenco T, Armstrong N, N'Dow J, et al,. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment 2008; 12: iii-x, 1
25. Lourenco T, Pickard R, Vale L, et al,. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ 2008; 337: a1662
26. Lourenco T, Pickard R, Vale L, et al,. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 2008; 337: a449
27. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M,. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004; 172: 616-9 (Pubitemid 38900219)
28. Stafinski T, Menon D, Harris K, Gray G, Jhangri G,. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Can Urol Assoc J 2008; 2: 124-34
29. Burke N, Whelan JP, Goeree L, et al,. Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology 2010; 75: 1015-22
30. Shingleton WB, Farabaugh P, May W,. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002; 60: 305-8 (Pubitemid 34831777)
31. Shingleton WB, Kolski JM, Renfroe DL, Fowler JE,. Electrovaporization of the prostate versus laser ablation of the prostate in men with benign prostatic hypertrophy: a pressure-flow analysis. Urol Int 1998; 60: 224-8 (Pubitemid 28408572)
32. Shingleton WB, Renfroe LD, Kolski JM, Fowler JE,. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998; 32: 266-9 (Pubitemid 28387177)
33. Shingleton WB, Terrell F, Renfroe DL, Kolski JM, Fowler JE,. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999; 54: 1017-21
34. Aho TF, Gilling PJ,. Current techniques for laser prostatectomy: PVP and HoLEP. Arch Esp Urol 2008; 61: 1005-13
35. ECRI Evidence Based Practice Center. Treatments for benign prostatic hyperplasia. 2004. Available at:. Accessed November 2009